2023 Form 5500 filing — Arl Bio Pharma, Inc./Dna Solutions, Inc. 401(K) Savings Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20240905164436NAL0047002674001) for Arl Bio Pharma, Inc./Dna Solutions, Inc. 401(K) Savings Plan, reported by Arl Bio Pharma, Inc. under EIN 73-1548108 and plan number 001. It reports 160 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20240905164436NAL0047002674001
Filing year
2023
Form type
2
Plan sponsor
Arl Bio Pharma, Inc.
EIN
73-1548108
Plan number
001
Location
Oklahoma City, OK
Participants
160
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$8,532,597
Total liabilities (EOY)
$0
Net assets (EOY)
$8,532,597
Employer contributions
$225,039
Participant contributions
$498,137
Total income / additions
$8,766,259
Benefits paid
$242,887
Administrative expenses
$15,887
Total expenses
$258,774
Net increase / (decrease)
$8,507,485
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
BancfirstINVESTMENT ADVISOR$9,758not reported in the loaded dataset
Empower Annuity Insurance Company ORECORDKEEPER$6,098$0
Empower Advisory Group, LLCINVESTMENT MGMT$31not reported in the loaded dataset

Related Form 5500 pages